Search results
Showing 31 to 45 of 163 results for copd
services – these patient groups (and COPD) present to AMU. NICE NG15 COPD guidance re-iterates that fundamentals of...
antibiotics for preventing exacerbations:- Which subgroups of people with stable COPD who are at high risk of exacerbations are most...
How providers and commissioners can use quality standards to improve the quality of care
Ensuring access to Pulmonary Rehabilitation for a deaf service user
line with NICE guidance for diagnosis and management of chronic obstructive pulmonary disease (COPD) in over 16's (NG115)....
extensive evidence for PR in patients suffering from chronic obstructive pulmonary disease (COPD) but much less for ILD....
clinical and cost-effective treatments for pulmonary hypertension in people with COPD? Any explanatory notes(if applicable) N/A Source...
Multidimensional assessment of outcomes- How can the individual factors associated with COPD prognosis (collected from a range of...
Recommendation ID NG115/11 Question Mucolytic therapy:- In people with COPD, does mucolytic drug therapy prevent exacerbations in...
predict inhaled corticosteroid responsiveness most accurately in people with COPD? Any explanatory notes(if applicable) Why this is...
Smoking: smoking status of people with long-term conditions (IND156)
This indicator covers the percentage of patients with any or any combination of the following conditions: CHD, PAD, stroke or TIA, hypertension, diabetes, COPD, CKD or asthma, whose notes record smoking status in the preceding 12 months. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as NM126
NICE indicators on: cardiovascular disease prevention (risk assessment) COPD (annual review) postnatal support (6-week postnatal check)...
Smoking: smoking status for people with long-term conditions (IND97)
This indicator covers the percentage of patients with any or any combination of the following conditions: CHD, PAD, stroke or TIA, hypertension, diabetes, COPD, CKD, asthma, schizophrenia, bipolar affective disorder or other psychoses whose notes record smoking status in the preceding 12 months. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as NM38
seasonal versus continuous prophylactic antibiotics for people with stable COPD who are at high risk of exacerbations? Any explanatory...
Lung volume reduction surgery for advanced emphysema (IPG114)
Evidence-based recommendations on lung volume reduction surgery for treating advanced emphysema. This involves removing damaged lung tissue using a special stapling device, a laser, or both.
View recommendations for IPG114Show all sections
Sections for IPG114
and cost effectiveness of prophylactic antibiotics for people with stable COPD who are at high risk of exacerbations? Any explanatory...